ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
5,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
9,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
12,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
13,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
13,2,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
13,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
14,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
15,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
16,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
17,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
17,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
18,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
18,2,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
18,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
18,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
18,5,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
19,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
19,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
20,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
21,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
21,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
22,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
23,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
23,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
24,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
24,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
24,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
24,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
25,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
26,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
26,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
27,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
27,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
28,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
28,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
28,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
28,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,5,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
29,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
29,2,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
29,3,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
29,4,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
29,5,Deafness,Hearing losses,Hearing disorders,Ear,N
29,6,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
29,7,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
29,8,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
29,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
29,10,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
29,11,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
29,12,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
29,13,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
30,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
30,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
31,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
31,3,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,5,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
32,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
32,2,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,1,Helminthic infection,Helminthic infections NEC,Helminthic disorders,Infec,N
34,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
35,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
36,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
36,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
37,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,1,Acne,Acnes,Skin appendage conditions,Skin,N
39,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
39,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
40,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
40,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
41,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
41,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
41,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
42,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
43,1,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
44,1,Hyperchlorhydria,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
44,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
44,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
45,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
45,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
45,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
45,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
46,1,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
47,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
47,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
48,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
49,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
49,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
50,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
50,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
50,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
51,1,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
52,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
53,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
53,2,Short-bowel syndrome,Malabsorption syndromes,Malabsorption conditions,Gastr,N
54,1,Blood electrolytes decreased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
54,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
55,1,Disability,Disability issues,Lifestyle issues,SocCi,N
55,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
55,3,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
55,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
55,5,Patella fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
55,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
56,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
56,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
57,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
57,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
57,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
58,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
58,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
58,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
59,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
60,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
61,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
61,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
62,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
62,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
62,4,Short-bowel syndrome,Malabsorption syndromes,Malabsorption conditions,Gastr,N
63,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
63,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
63,3,Immobile,Disability issues,Lifestyle issues,SocCi,N
64,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
64,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
64,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
64,5,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
64,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
64,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
64,8,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
64,9,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
64,10,Vascular graft,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
65,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
66,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,1,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
68,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
68,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
68,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
68,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
69,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
70,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
70,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
71,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
71,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
72,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
72,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
72,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
73,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
73,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
73,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
73,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
73,5,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
74,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
75,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
75,2,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
75,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
76,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
77,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
78,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
78,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,1,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
79,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
80,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
80,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
81,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
83,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
83,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
